NCT00355316View on ClinicalTrials.gov

A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients

NACompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

November 30, 2012

Study Completion Date

February 28, 2013

Conditions
Breast Neoplasms
Interventions
OTHER

Blood draw

Trial Locations (2)

29425

Medical University of South Carolina, Charleston

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Washington University School of Medicine

OTHER

NCT00355316 - A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients | Biotech Hunter | Biotech Hunter